Education
About Us
Working with TipRanks
Follow Us
Procept Biorobotics Corp. (PRCT)
:PRCT
PRCT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$37.12 - $103.81
Previous CloseN/A
Volume113.34K
Average Volume (3M)1.37M
Market Cap
$2.26B
Enterprise Value$2.97B
Total Cash (Recent Filing)$316.21M
Total Debt (Recent Filing)$81.81M
Price to Earnings (P/E)―
Beta1.25
Next Earnings
Oct 30, 2025EPS Estimate
-0.41Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.35
Shares Outstanding55,635,940
10 Day Avg. Volume935,721
30 Day Avg. Volume1,366,442
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.31
Enterprise Value/Revenue11.92
Enterprise Value/Gross Profit19.17
Enterprise Value/Ebitda-36.83
Forecast
1Y Price Target
$69.00Price Target Upside69.62% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
Bulls Say, Bears Say
Bulls Say
Financial PerformanceProcept Biorobotics Corp pre-announced second quarter revenue 4% above consensus, demonstrating strong commercial momentum.
Growth PotentialAll indications are positive for near- and long-term growth in a market only 15% penetrated with TAM expansion execution ongoing.
LeadershipLarry Wood, an industry veteran, is appointed as the new CEO of Procept Biorobotics Corp, bringing valuable perspective and expertise.
Bears Say
GuidanceThe updated guidance came in potentially softer than expected, with raised FY25 sales guidance implying reduced sales compared to consensus.
Investor ConcernsThe newly announced CCO transition on top of a CEO transition will create concerns about the business.
Stock PerformanceProcept Biorobotics Corp shares are down 27% year-to-date, despite the company's strong financial performance.
PROCEPT BioRobotics News
PRCT FAQ
What was Procept Biorobotics Corp.’s price range in the past 12 months?
Procept Biorobotics Corp. lowest stock price was $37.12 and its highest was $103.81 in the past 12 months.
What is Procept Biorobotics Corp.’s market cap?
Procept Biorobotics Corp.’s market cap is $2.26B.
When is Procept Biorobotics Corp.’s upcoming earnings report date?
Procept Biorobotics Corp.’s upcoming earnings report date is Oct 30, 2025 which is in 52 days.
How were Procept Biorobotics Corp.’s earnings last quarter?
Procept Biorobotics Corp. released its earnings results on Aug 06, 2025. The company reported -$0.35 earnings per share for the quarter, beating the consensus estimate of -$0.415 by $0.065.
Is Procept Biorobotics Corp. overvalued?
According to Wall Street analysts Procept Biorobotics Corp.’s price is currently Undervalued.
Does Procept Biorobotics Corp. pay dividends?
Procept Biorobotics Corp. does not currently pay dividends.
What is Procept Biorobotics Corp.’s EPS estimate?
Procept Biorobotics Corp.’s EPS estimate is -0.41.
How many shares outstanding does Procept Biorobotics Corp. have?
Procept Biorobotics Corp. has 55,635,940 shares outstanding.
What happened to Procept Biorobotics Corp.’s price movement after its last earnings report?
Procept Biorobotics Corp. reported an EPS of -$0.35 in its last earnings report, beating expectations of -$0.415. Following the earnings report the stock price went down -13.351%.
Which hedge fund is a major shareholder of Procept Biorobotics Corp.?
Currently, no hedge funds are holding shares in PRCT
PROCEPT BioRobotics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$69.00 (69.62% Upside)
$69.00 (69.62% Upside)
Blogger Sentiment
Bullish
PRCT Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 199.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $785.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 17.2%
Last 30 Days ▲ 19.8%
Last 30 Days ▲ 19.8%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-46.71%
12-Months-Change
Fundamentals
Return on Equity
-26.40%
Trailing 12-Months
Asset Growth
37.05%
Trailing 12-Months
Company Description
Procept Biorobotics Corp.
PROCEPT BioRobotics Corporation (PRCT) is a medical technology company specializing in the development of innovative robotic solutions for the treatment of urological diseases. The company's flagship product, the AquaBeam Robotic System, utilizes advanced imaging and robotics to perform minimally invasive surgery for benign prostatic hyperplasia (BPH), a common condition affecting older men. By focusing on enhancing patient outcomes and reducing the side effects associated with traditional surgical methods, PROCEPT BioRobotics aims to revolutionize the standard of care in the urology sector.
PRCT Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong performance in revenue growth, both domestically and internationally, and improvements in gross margins and tariff conditions. The company has increased its financial guidance for the year and received a positive update on Medicare reimbursement. However, there are concerns over leadership changes and financial metrics like net loss and adjusted EBITDA, although these are improving. Overall, the positive aspects outweigh the challenges.View all PRCT earnings summariesPRCT Stock 12 Month Forecast
Average Price Target
$69.00
▲(69.62% Upside)
Technical Analysis
Ownership Overview
2.74% Insiders
36.57% Mutual Funds
26.95% Other Institutional Investors
18.06% Public Companies and
Individual Investors